• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • COVID-19
  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • Artificial Intelligence
    • Blockchain
    • Mobile Health
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Survey Reveals Hospital Supply Chain Still Stuck in the “Stone Age”

by Fred Pennic 03/06/2014 Leave a Comment

Senior hospital executives cite hospital supply chain specifically in the operating room as a major obstacle to lowering overall healthcare costs. 

Despite the fact the healthcare industry is fueled by scientific advancement, too many hospitals find themselves stalled at a crossroads, struggling to embrace business-focused technologies and best practices that will allow them to flourish in the decades to come. This is the troubling picture painted by results of a new independent survey released by GHX.

The GHX survey of 75 hospital senior executives indicates that operating room (OR) supply chain deficiencies have slowed organizational decision-making, increased costs and inefficiency — and ultimately impact the delivery of patient care. Conducted by KRC Research, the survey included executives within hospitals larger than 125 licensed beds who have decision-making authority or influence related to the purchase and management of implantable medical devices in the operating room.

While the research results point out a problem, they also spotlight a tremendous opportunity for industry, which is to find a way to transform the OR supply chain into a strategic function that’s as technologically-advanced as the OR itself – with an overall goal to lower healthcare costs.

“Today there aren’t widely-adopted, end-to-end supply chain management processes for implantable devices as there are for medical-surgical supplies. As a result, the operating room has become one of the most siloed areas in a hospital,” said Bruce Johnson, president and CEO, GHX. “Implantable devices are estimated to account for approximately $50 billion as a market segment.Lack of visibility and control over these devices cost the healthcare industry an estimated $5 billion per year from inefficient manual processes, and lost, expired and wasted product. Until suppliers and providers fully embrace technology to streamline processes and reduce waste, our nation’s healthcare system will never be able to lower costs for consumers in any meaningful way.”

Related: 4 Best Practices for Streamlining Hospital Supply Chain Management

Key Research Findings:

Too Many Hospitals Stuck in the Supply Chain “Stone Age”

  • · 79 percent of senior hospital executives say keeping supply chain costs down is important to addressing key financial challenges, such as a decline in profit margins and shrinking reimbursements from government and private payers.
  • 78 percent of respondents report hospitals are playing catch-up in terms of implementing effective supply chain technology solutions.
  • One-in-five (18 percent) say they’re still stuck in the “Stone Age” – dramatically lagging behind where they could and should be.

The Lack of Supply-Chain Visibility in the OR Comes at a High Cost

  • · Nearly two in three executives “strongly agree/agree” that their hospital lacks real-time reports (62 percent) and advanced modeling techniques to inform decision-making (65 percent) when it comes to their hospital’s implantable medical device supply chain, making the streamlining of delivery of care in their hospital an even more significant hurdle.
  • · Seventy percent of respondents say excess clinical time spent on inventory replenishment is a “very” or “somewhat significant” challenge to their hospital’s operating room.
  • Almost half of respondents (45 percent) “strongly agree/agree” there is a lack of accurate implantable medical device supply chain reports.

“Where’s that Hip When I Need It?” – Supply Chain Failings Trigger Procedure Delays, Recall Challenges for Hospital ORs

  • · Especially alarming is the role the supply chain plays in potentially having an adverse impact on efficiency and cost savings in the operating room:
  • 55 percent of respondents say that surgical procedure delays due to sales reps ordering medical-surgical devices are a“very” or “somewhat significant” challenge.
  • 53 percent of respondents say staff ability to locate medical-surgical supplies when needed is a “very” or “somewhat significant” challenge.
  • 74 percent of respondents report their hospital has a system that allows them to track (and recall, if necessary) devices that are implanted in specific patients
  • 47 percent admit it would be “very difficult” or “somewhat difficult” to track patients with implantable devices if there was a recall on a particular device.

Related: 5 Ways Supply Chain Can Reduce Rising Healthcare Costs

Featured image credit: Etrusia UK via cc

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Most Popular

Survey: Clinician Burnout Is A Public Health Crisis Demanding Urgent Action

17 Execs Share How Health IT Can Address Clinician Burnout, Staffing, & Capacity

Q/A: Dr. Johnson Talks Racial Disparities in Breast Cancer Care

Q/A: Dr. Johnson Talks Racial Disparities in Breast Cancer Care

Northwell Health Extends Contract with Allscripts Sunrise Platform Through 2027

Northwell to Deploy Epic Enterprise EHR Platform Across System

Sanofi Cuts Price of Lantus Insulin by 78% & Caps Out of Pocket Costs at $35 for All Patients

Sanofi Cuts Price of Lantus Insulin by 78% & Caps Out of Pocket Costs at $35 for All Patients

Pfizer Acquires Seagen for $43B to Tackle Cancer

Pfizer Acquires Seagen for $43B to Tackle Cancer

5 Key Trends Driving Purchasing Decisions in Healthcare IT

5 Key Trends Driving Purchasing Decisions in Healthcare IT

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

Dr. Arti Masturzo

Q/A: Dr. Masturzo Talks Addressing Food Insecurity with Patients

Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business

Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business

Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • 2023 Editorial Calendar
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2023. HIT Consultant Media. All Rights Reserved. Privacy Policy |